RAIsonance, a group of AI-powered companies focused on natural language processing and AI/ML, announced the release of SoundPass, a trio of AI apps that transform sound data signatures into biometric signal data signatures.

SoundPass uses artificial intelligence to create a biometric perimeter security bubble around workplaces, entertainment venues, public-facing businesses, and college campuses.

The product was designed to bring students back to school and employees back to the office this fall with scalable, efficient controls in place that address the challenges society is currently encountering.

The app learns the unique forced cough signature of each user, which is then securely stored as that user’s baseline for future comparison. If the signature is the same, the user gets an “authenticated” message.

However, if the signatures do not match, the user gets a “not authenticated” message, providing an early warning of a possible problem. Conditions that can alter a baseline forced cough sound include illness and environmental exposure

The apps come in three editions, Personal, Plus and Access. Personal is free of charge. Plus costs $25 per person, per year, and generates a scannable QR code each time a user authenticates a new forced cough signature to their baseline. The Access app is used to scan the QR code of anyone using SoundPass Plus.

Founded in 2020 in response to COVID-19, and partially funded by National Science Foundation, RAIsonance’s solutions target safety, security and healthcare diagnostics markets, using signal-data signature recognition as a biomarker for human medical diagnostics and in support of safety applications.

"We see a significant opportunity going forward for many different players, some of which we’re actively working to partner with,” Kitty Kolding, CEO of RAIsonance, told MobiHealthNews. “For ourselves, given the approach we take to using AI/ML for security and health purposes, the opportunities are wide open.”

She noted RAIsonance has at least two new products in development to be released on their 2021 road map, all using the same basic capabilities they’ve developed, but serving specific, timely needs in the U.S. and the world.

RAIsonance also has a second product under development, an AI software-as-a-medical device (SaMD) diagnostic for a range of respiratory conditions.

The company recently joined Microsoft for Startups program, giving RAIsonance access to the tech giant’s technologies, including Azure, and to a streamlined path to selling alongside Microsoft and its global partner ecosystem.

“The Microsoft for Start Ups program is really incredible for a start-up,” Kolding said. “Part of the value is the series of credits they offer for software and Azure server utilization which is direct savings for us, and has allowed us to expedite our extensive AI/ML testing with very high capacity CPU and GPU servers.”